Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-001896 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 12, 2026 |
| Document Date | Jan 8, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
50,659
Total Value
$91,073.23
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 8, 2026 | Sale | 6,819 | $1.82 | $12,379.21 | 127,640 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 8, 2026 | Sale | 30,092 | $1.82 | $54,866.74 | 97,548 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 9, 2026 | Sale | 5,200 | $1.76 | $9,169.16 | 92,348 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 12, 2026 | Sale | 8,548 | $1.71 | $14,658.11 | 83,800 | Direct | โ | View Details |